What changed
$DRI — AVOID 📊 | 6 MONTHS THESIS
🧭 Conviction: HIGH
🎯 FQ4 FY2027 (ends May) | reported Jun 25 | Rev $3.3B | EPS $3.66 vs $3.63 🟢 | Margin 12.2%
💡 The slight EPS beat of 0.8% is negligible; the real gap is that consensus likely expects stable margins or recovery, while operating income declined YoY. The market might be too optimistic about earnings stability, giving an opportunity to fade the stock if margins continue to compress. From a long perspective, no positive gap exists.
🏢 Business Quality: 5/10
📊 Valuation: appears cheap on trailing P/E of 14.6x relative to historical consumer discretionary averages, but EV/EBITDA of 12.2x is roughly in line with...
🔮 Catalyst: Next quarterly earnings
⚖️ Avoid DRI due to declining operating performance, lack of positive catalyst, and extremely unfavorable quantitative factor ranking.